Inhibition of NF-κB-inducing kinase (NIK) disrupts NF-κB- and STAT-signaling crosstalk, resensitizing CLL cells to venetoclax [83]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.